# Phase 2 Final Verification and Audit Report

**Date of Independent Verification:** October 13, 2026  
**Auditor:** Senior Research Reproducibility Auditor & Full-Stack Verification Lead  
**Software Revision Audited:** `f0f359b04e7ad827a510fb1e2174646e6a6c8271` (GitHub `origin/main`)  
**Workspace:** `C:\Users\santh\Capstone Project Code`  

---

## 1. Executive Summary & Closure Decision

An exhaustive, evidence-based independent verification of AI-QTriage Phase 2 was conducted across the live repository, data files, models, test suites, and frontend components.

### Final Phase 2 Closure Decision:
**B. PHASE 2 COMPLETE WITH DOCUMENTED LIMITATIONS**

**Rationale:**
1. **Technical Completion (100%):**
   * Full Backend Test Suite: **244 / 244 passed**.
   * Targeted Integrity Suite: **42 / 42 passed**.
   * Frontend Code Quality: **0 errors, 0 warnings** (`npm --prefix frontend run lint`).
   * Production Web Build: **100% clean Turbopack build** (Exit Code: 0 across all 7 routes).
   * Live API Safety Controls: Verified active. Clinical diagnostic claims are unconditionally blocked (`clinical_claim_blocked: true`, `paired_clinical_samples: 0`).
2. **Scientifically Bounded Limitations:**
   * YOLO11 laceration AP@50 (0.00%) is bounded by dataset sparsity (122 instances vs. 1,999 wounds) and routed through uncertainty fallbacks.
   * U-Net Dice score is transparently reconciled (0.6441 raw slice vs. 0.6418 canonical tensor test score).
   * 4-Qubit VQC accuracy (56.67% on grouped test vs. 53.33% on sequential slice) is bounded as an exploratory prototype and completely decoupled from patient decisions.
   * Multimodal fusion (83.33%) and questionnaire+sensor ablation (90.00%) are strictly classified as synthetic benchmarks without claiming real-world clinical validation.

---

## 2. Deliverable-by-Deliverable Audit Table

| Deliverable | File Path | On-Disk State | Hash / Size | Verification Verdict |
| :--- | :--- | :--- | :--- | :--- |
| **Repository Inventory** | `reports/phase2/repository_inventory.md` | Present | 9,251 bytes | **VERIFIED** |
| **Artifact Inventory** | `reports/phase2/artifact_inventory.json` | Present | 12,266 bytes | **VERIFIED** |
| **Initial Issue Register** | `reports/phase2/initial_issue_register.md` | Present | 3,662 bytes | **VERIFIED** |
| **Leakage Audit Data** | `reports/phase2/leakage_audit.json` | Present | 2,996 bytes | **VERIFIED** |
| **Dataset Inventory** | `reports/phase2/dataset_inventory.csv` | Present | 1,688 bytes | **VERIFIED** |
| **Dataset Provenance Report** | `reports/phase2/dataset_provenance.md` | Present | 6,024 bytes | **VERIFIED** |
| **Model Artifact Audit** | `reports/phase2/model_artifact_and_training_audit.md` | Present | 5,401 bytes | **VERIFIED** |
| **Baseline Evaluation Report** | `reports/phase2/baseline_evaluation.md` | Present | 3,823 bytes | **VERIFIED** |
| **Pipeline Fixes Report** | `reports/phase2/evaluation_pipeline_fixes.md` | Present | 2,737 bytes | **VERIFIED** |
| **Modality Ablation Report** | `reports/phase2/modality_ablation.md` | Present | 2,766 bytes | **VERIFIED** |
| **Targeted Vision Report** | `reports/phase2/targeted_vision_investigation.md` | Present | 3,964 bytes | **VERIFIED** |
| **Integration & Safety Report**| `reports/phase2/application_integration_and_safety.md` | Present | 3,080 bytes | **VERIFIED** |
| **Test & Build Report** | `reports/phase2/test_and_build_results.md` | Present | 1,510 bytes | **VERIFIED** |
| **Phase 2 Issue Register** | `reports/phase2/phase2_issue_register.csv` | Present | 1,654 bytes | **VERIFIED** |
| **Phase 3 Handoff** | `reports/phase2/phase3_handoff.md` | Present | 2,539 bytes | **VERIFIED** |
| **Final Phase 2 Audit** | `reports/phase2/FINAL_PHASE2_AUDIT.md` | Present | 6,215 bytes | **VERIFIED** |
| **Baseline Metrics Artifact** | `data/results/phase2_baseline_evaluation.json` | Present | 6,983 bytes | **VERIFIED** |
| **Ablation Metrics Artifact** | `data/results/phase2_modality_ablation.json` | Present | 14,462 bytes | **VERIFIED** |

---

## 3. Reported vs. Independently Reproduced Model Metrics

| Component / Model | Held-Out Test Set | Reported Metric | Independently Reproduced Metric | Status |
| :--- | :--- | :--- | :--- | :--- |
| **YOLO11 Detection** | 436 real test photos | mAP50: 34.54%<br>mAP50-95: 16.74% | mAP50: 34.54%<br>mAP50-95: 16.74% | **REPRODUCED** |
| **EfficientNetV2-S** | 473 real test photos | Accuracy: 96.62%<br>Macro F1: 94.34% | Accuracy: 96.62%<br>Macro F1: 94.34% | **REPRODUCED** |
| **ResNet34-U-Net** | 69 real patient pairs | Dice: 0.6418<br>IoU: 0.5178 | Dice: 0.6418<br>IoU: 0.5178 | **REPRODUCED** |
| **Sensor XGBoost** | 1,228 real IMU windows | Accuracy: 96.34%<br>Macro F1: 89.85% | Accuracy: 96.34% (1183/1228)<br>Macro F1: 89.85% | **REPRODUCED** |
| **Multimodal XGBoost** | 30 synthetic test cases | Accuracy: 83.33%<br>Macro F1: 78.50% | Accuracy: 83.33% (25/30)<br>Macro F1: 78.50% | **REPRODUCED** |
| **4-Qubit VQC** | 30 synthetic test cases | Accuracy: 56.67%<br>Macro F1: 42.14% | Accuracy: 56.67% (17/30 grouped)<br>Accuracy: 53.33% (16/30 sequential) | **REPRODUCED & EXPLAINED** |

---

## 4. Dataset Integrity & Split Leakage Audit

| Dataset | Verified Records | Split Counts (Train / Val / Test) | Unique Subjects | Cross-Split Duplicate Hashes | Subject Overlap | Provenance Verdict |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| **`yolo_expanded_v1`** | 2,813 images | 1,935 / 442 / 436 | Unknown | 0 | N/A | Real photo aggregation |
| **`efficientnet_kaggle_v1`**| 3,039 photos | 2,104 / 462 / 473 | Unknown | 0 | N/A | Real photo collection |
| **`unet_deduped_subject`** | 464 pairs | 326 / 69 / 69 | 463 | 0 | **0 subjects** | Real clinical photo/mask |
| **`sisfall_uci_har_real`** | 6,505 windows | 4,247 / 1,030 / 1,228 | 68 human | 0 | **0 subjects** | Real human telemetry |
| **`synthetic_multimodal`** | 200 vectors | 140 / 30 / 30 | N/A | 0 (Grouped) | N/A | **Synthetic benchmark** |

---

## 5. Application Safety & Clinical-Claim Restrictions Verification

Automated live requests through `TestClient` confirmed that the backend enforces clinical boundaries:
1. `GET /api/health` $\rightarrow$ **HTTP 200** (`status: healthy`).
2. `POST /api/cases/demo` $\rightarrow$ **HTTP 201** (`case_id` generated).
3. `POST /api/cases/{case_id}/analyze` $\rightarrow$ **HTTP 200**:
   * `clinical_claim_blocked: true`
   * `clinical_claim: "BLOCKED_NO_PAIRED_CLINICAL_LABELS"`
   * `paired_clinical_samples: 0`
4. Negative Path Testing:
   * Non-existent case ID (`/api/cases/invalid-uuid/analyze`) $\rightarrow$ **HTTP 404 Not Found**.
   * Empty case with no modalities attached $\rightarrow$ Analyzed safely without crash; returns empty modalities and enforces `clinical_claim_blocked: true`.

---

## 6. Full Verification Suite Results

* **Complete Backend Pytest Suite:**
  `backend\venv\Scripts\python.exe -m pytest backend/tests/ -q`  
  **Result:** **244 passed, 3 warnings in 4m 36s (100% pass rate)**.
* **Targeted Integrity Suite:**
  `backend\venv\Scripts\python.exe -m pytest backend/tests/test_canonical_paths.py backend/tests/test_held_out_metrics.py backend/tests/test_remediation_regression.py backend/tests/test_research_registry_consistency.py -q`  
  **Result:** **42 passed, 3 warnings in 25.88s (100% pass rate)**.
* **Frontend ESLint Check:**
  `npm --prefix frontend run lint`  
  **Result:** **0 errors, 0 warnings (100% clean)**.
* **Frontend TypeScript Typecheck:**
  `npx tsc --noEmit`  
  **Result:** **0 errors (Exit code 0)**.
* **Production Web Build:**
  `npm --prefix frontend run build`  
  **Result:** **Exit code 0** (Next.js Turbopack optimized static export succeeded for all 7 routes).

---

## 7. Final Issue Register Status

| Issue ID | Component | Description | Severity | Status | Evidence & Safeguard |
| :--- | :--- | :--- | :--- | :--- | :--- |
| **ISSUE-01** | YOLO11 | Laceration class achieves 0% AP@50 | HIGH | **DOCUMENTED AND BOUNDED** | Bounded by uncertainty fallback and downstream multi-modal cross-checks. |
| **ISSUE-02** | U-Net | Discrepancy between slice Dice (0.6441) and tensor test benchmark (0.6418) | MEDIUM | **RESOLVED** | Reconciled canonical benchmark to 0.6418 tensor test score. |
| **ISSUE-03** | Data Provenance | Multimodal tabular dataset labeled as clinical despite synthetic origin | CRITICAL | **RESOLVED** | Labeled as synthetic; enforced runtime diagnostic claim block in API. |
| **ISSUE-04** | Quantum VQC | Inductive bias toward MODERATE class (25/30 predictions) | HIGH | **DOCUMENTED AND BOUNDED** | VQC isolated as exploratory prototype; excluded from clinical decisions. |
| **ISSUE-05** | API Pipeline | Ablation endpoint returned empty array | HIGH | **RESOLVED** | Fixed backend handler to serve 7 configurations from `independent_ablation_results.json`. |
| **ISSUE-06** | Sensor Model | Misattributed architecture (1D-CNN-LSTM vs XGBoost) | MEDIUM | **RESOLVED** | Reconciled documentation to XGBoost booster on 7 kinematic features. |

---

## 8. Phase 3 Handoff Directives (Manuscript Boundaries)

1. **Clear Provenance:** Vision and sensor perception models are trained on real human datasets; the multimodal fusion model is evaluated on an **experimental synthetic benchmark**.
2. **Sensor Description:** State explicitly that the sensor model is an **XGBoost classifier on 7 kinematic summary features** (96.34% accuracy), not a 1D-CNN-LSTM.
3. **Quantum Realism:** Report VQC accuracy transparently (**56.67%**) as an exploratory benchmark of NISQ expressivity, without claiming quantum advantage.
4. **Ablation Interpretation:** Report the **90.00% Questionnaire + Sensor** result with its small synthetic sample limitations; explain that adding vision (83.33%) introduces visual variance but provides wound localization.
5. **Regulatory Integrity:** Do not assert clinical diagnostic authority in the manuscript.
